NCT00082459View on ClinicalTrials.gov

Trial to Compare the Routes of Administration of an Investigational, Personalized, Therapeutic Cancer Vaccine Oncophage (HSPPC-96) in Patients With Metastatic Renal Cell Carcinoma

PHASE2TerminatedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

July 31, 2002

Primary Completion Date

December 31, 2005

Study Completion Date

December 31, 2005

Conditions
Renal Cell Carcinoma
Interventions
BIOLOGICAL

autologous human tumor-derived HSPPC-96

Trial Locations (1)

Unknown

Houston

Sponsors

Lead Sponsor

Agenus Inc.
All Listed Sponsors
lead

Agenus Inc.

INDUSTRY